Posted at eNewsWire by chrisb on Thursday, August 14, 2008eNewsWire Category: Featured, Health and Pharmaceuticals
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer.
Actavis Group, the international generic drug company, has announced that it has appointed Gudbjorg Edda Eggertsdottir as Deputy CEO.
Valur Ragnarsson will become the new Executive Vice President of Third-Party Sales and Doug Boothe will be [...]
Popularity: 5% [?]
Posted at eNewsWire by chrisb on Thursday, August 7, 2008eNewsWire Category: Featured, Health and Pharmaceuticals
Generic pharmaceutical company Actavis will launch its first ever over the counter (OTC) oral antibiotic in the UK.
Actavis, a generic drug manufacturer, has announced it will launch Clamelle Azithromycin at pharmacies across the UK - the first oral antibiotic available without a doctor’s prescription.
Clamelle is used for the treatment of people with chlamydia and for [...]
Popularity: 5% [?]
Posted at eNewsWire by chrisb on Monday, July 21, 2008eNewsWire Category: Featured, Health and Pharmaceuticals
Actavis, the international generic pharmaceuticals company, recently launched Bicalutamide tablets in the UK, Germany and France. Acuavis Bicalutamide is the first generic version of the oncology drug to be made available in the three markets.
Actavis has launched a generic drug for prostate cancer, Bicalutamide, in the UK, France and Germany.
Bicalutamide, the generic version of AstraZeneca’s [...]
Popularity: 7% [?]
Posted at eNewsWire by AElliott on Thursday, July 10, 2008eNewsWire Category: Featured, Health and Pharmaceuticals, Marketing and Consulting
Reykjavik, Iceland, 10 July 2008 — Actavis Group, the international generic pharmaceuticals company, today announced the launch of Bicalutamide tablets in the United Kingdom, Germany and France. Bicalutamide Actavis is the first generic version of the oncology drug to be made available in the three markets.
Bicalutamide, the generic version of AstraZeneca’s Casodex®, is used as [...]
Popularity: 5% [?]
Posted at eNewsWire by AElliott on Sunday, June 15, 2008eNewsWire Category: Featured, Health and Pharmaceuticals
The Iceland-based generic drugs manufacturer Actavis announces the opening of a new disabled access ramp to a major Bulgarian cathedral.
Actavis has financed the construction of an access ramp for disabled people to a large cathedral in Bulgaria. The ramp was officially opened by Nikolay Hadjidonchev, Actavis’ Bulgaria Managing director, in the presence of admiral Hristo [...]
Popularity: 10% [?]